Literature DB >> 19506047

Effect of demographic characteristics and timing of vascular access maturation on patency in Chinese incident haemodialysis patients.

Yee-Yung Ng1, Shiao-Chi Wu, Yen-Ni Hung, Po-Jen Ko.   

Abstract

BACKGROUND: Functional, long-lasting vascular access is essential for maintaining effective long-term haemodialysis. Previous studies have documented demographic factors and comorbid conditions associated with long-term vascular access. However, no studies have examined the effect of demography and timing of vascular access maturation on primary patency in Chinese incident haemodialysis patients.
METHODS: We retrospectively enrolled 7028 adult incident patients who began haemodialysis between 1 January and 31 December 2002. A total of 5890 patients with mature arteriovenous fistula or arteriovenous graft, before or after beginning regular haemodialysis, were identified between 1 January 2000 and 31 December 2003. The Cox regression hazard model was used to assess the impact of sex, age, diabetes, type of access and timing of vascular access maturation on the duration of primary vascular access patency.
RESULTS: Of the study population, 2920 patients (50%) had diabetes; 4929 patients (84%) received fistulas and 961 (16%) grafts. Grafts, female sex and advanced age were significantly associated with shorter primary vascular access patency duration (P < 0.05). Diabetes was a risk factor for shorter primary vascular access patency duration for incident patients with mature fistulas before or after initiation, but not for patients with mature graft. Arteriovenous graft placement and maturation were better when completed >6 months prior to haemodialysis initiation for the duration of primary access patency.
CONCLUSION: Demographic characteristics and timing of vascular access maturation affect access type and duration of primary access patency among incident patients. Individual programmes for vascular access may be necessary to establish functional long-term access.

Entities:  

Mesh:

Year:  2009        PMID: 19506047     DOI: 10.1093/ndt/gfp269

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Initial clinical use of a novel mechanical thrombectomy device, XCOILTM, in hemodialysis graft and fistula declot procedures.

Authors:  Wayne L Monsky; Richard E Latchaw
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

2.  The longevity of arteriovenous graft for hemodialysis patients--externally supported or nonsupported.

Authors:  Yen-Ni Hung; Po-Jen Ko; Yee-Yung Ng; Shiao-Chi Wu
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 8.237

3.  Re-envisioning Fistula First in a patient-centered culture.

Authors:  Amanda Gomes; Rebecca Schmidt; Jay Wish
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

4.  Effect of Aging in the Perception of Health-Related Quality of Life in End-Stage Renal Disease Patients under Online-Hemodiafiltration.

Authors:  Alexandra Moura; José Madureira; Pablo Alija; João Carlos Fernandes; José Gerardo Oliveira; Martin Lopez; Madalena Filgueiras; Leonilde Amado; Maria Sameiro-Faria; Vasco Miranda; Alice Santos-Silva; Elísio Costa
Journal:  Aging Dis       Date:  2014-05-25       Impact factor: 6.745

5.  Vascular access registry of Serbia: a 4-year experience.

Authors:  Tamara Jemcov; Nada Dimkovic
Journal:  Int Urol Nephrol       Date:  2016-07-27       Impact factor: 2.370

6.  Characteristics and 3-year mortality and infection rates among incident hemodialysis patients with a permanent catheter undergoing a first vascular access conversion.

Authors:  Yee-Yung Ng; Yen-Ni Hung; Shiao-Chi Wu; Po-Jen Ko
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

Review 7.  Current tools for prediction of arteriovenous fistula outcomes.

Authors:  Damian G McGrogan; Alexander P Maxwell; Aurang Z Khawaja; Nicholas G Inston
Journal:  Clin Kidney J       Date:  2015-04-02

8.  The arteriovenous access stage (AVAS) classification.

Authors:  Peter Baláž; Jennifer Hanko; Hannah Magowan; Agnes Masengu; Katarina Lawrie; Stephen O'Neill
Journal:  Clin Kidney J       Date:  2020-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.